Emergency Department Lung Cancer URMFG Pilot
This is a randomized controlled pilot trial of a text-based behavioral intervention aimed at increasing uptake of lung cancer screening among emergency department patients. We will conduct a 2-year randomized controlled clinical trial with a prospectively collected convenience sample of 366 adults who are eligible for LCS but non-adherent with LCS screening guidelines. Adults aged 50-80 will be recruited from a high-volume urban ED and a low-volume rural ED, assigned to study conditions, and followed-up at 150 days to assess interval engagement with the University of Rochester Medical Center's LCS screening program (primary outcome). Electronic Health Record (EHR) review will be conducted to assess screening results and subsequent clinical endpoints.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Aug 15, 2023 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Rochester
- Interventions being studied
- Behavioral: Text Messaging
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Age 50 - 80
- 20+ pack-year smoking history
- current smoker or quit within 15 years
- English, ASL, or Spanish speaking
- Presenting as a patient at the Strong Memorial or Noyes Community Hospital EDs
- Non-English, Non-Spanish, and Non-ASL speaking
- Inability to consent (e.g. high clinical acuity)
- Lack of text-capable mobile phone and/or inability to use text function
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Strong HospitalRochester, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 15, 2023. Always confirm current availability with the study team.